Veränderung im trigeminalen Schmerzsystem nach chemischer Stimulation der Dura mater

Zusammenfassung

Die Pathophysiologie chronischer Kopfschmerzen z. B. chronische Migräne oder chronischer Spannungskopfschmerz ist weitestgehend unbekannt. Basierend auf der Hypothese, dass inflammatorische Mechanismen an der Genese chronischer Kopfschmerzen beteiligt sind, haben wir in einem tierexperimentellen Modell die Dura mater von Ratten mit IL-1β (10 ng/ml) unilateral stimuliert um biochemische und molekulare Veränderungen in schmerzsensitiven intrakraniellen Geweben zu untersuchen. Die IL-1β-Applikation führt zur Expression von c-fos im ipsilateralen Trigeminuskern nach 3 h, die durch vorherige Gabe von Sumatriptan blockiert werden kann. Die lokale Stimulation mit IL-1β führt zur Inflammation mit COX-2-mRNA und Proteinexpression. Eine repetitive Stimulation führt zu erhöhter COX-2-Expression. Die CGRP-mRNA-Bestimmung im Ganglion trigeminale ergab mittels RT-PCR-Untersuchung keine Änderung der Expression. Zusammengefasst führt die IL-1β-Stimulation zur lokalen meningealen Inflammation und Aktivierung des trigeminalen Schmerzsystems. Die Identifikation weiterer Effekte einer repetitiven meningealen Stimulation kann zur Entdeckung pathophysiologisch relevanter Mechanismen führen, die zur Entstehung chronischer Kopfschmerzen beitragen.

Abstract

The pathophysiology of chronic headaches such as chronic migraine or chronic tension type headache is poorly understood. Based on the assumption that inflammory mechanisms are involved in the pathophysiology of chronic headaches we have used topic stimulation of the rat dura mater with IL-1β (10 ng/ml) to examine changes in headache relevant structures within the brain. IL-1β causes ipsilateral c-fos expression within the trigeminal nucleus caudalis after 3 hours which can be blocked by pre-treatment with sumatriptan. IL-1β induced inflammation comprises of COX-2 impression within the dura as demonstrated by rt-PCR and western blotting. COX-2 expression is more pronounced after repeated (3 days) stimulation. CGRP mRNA levels within trigeminal ganglion were unchanged. In summary, IL-1β stimulation causes local meningal inflammation and activation of the trigeminal nerve system. The investigation of the effects of repetitive meningeal stimulation will possibly identify mechanisms involved in the generation of chronic headaches.

Migräne - Dura mater - N. trigeminus - Inflammation

chronic headache - meninges - trigeminal

Literatur

• 1 Dalkara T, Zervas N T, Moskowitz M A. From spreading depression to the trigeminovascular system.  Neurol Sci. 2006;  27, Suppl 2 S86-90, Review
• 2 Mayberg M, Langer R S, Zervas N T, Moskowitz M A. Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man.  Science. 1981;  213 228-230
• 3 Mitsikostas D D, Sanchez del Rio M. Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine.  Brain Res Brain Res Rev. 2001;  35 20-35, Review
• 4 Reuter U, Sanchez del Rio M, Moskowitz M A. Experimental models of migraine.  Funct Neurol. 2000;  15, Suppl 3 9-18, Review
• 5 Olesen J, Diener H C, Husstedt I W. et al . Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.  N Engl J Med. 2004;  350 1104-1110
• 6 Diener H C. Pharmacological approaches to migraine.  J Neural Transm. 2003;  64, Suppl 35-63
• 7 Silberstein S, Tepper S, Brandes J, Diamond M. et al . Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine.  Neurology. 2004;  62 1552-1557
• 8 Bendtsen L, Jensen R. Tension-type headache: the most common, but also the most neglected, headache disorder.  Curr Opin Neurol. 2006;  19 305-309, Review
• 9 Stovner L J, Zwart J A, Hagen K. et al . Epidemiology of headache in Europe.  Eur J Neurol. 2006;  13 333-345, Review
• 10 Welch K M. Contemporary concepts of migraine pathogenesis.  Neurology. 2003;  61, 8 Suppl 4 S2-8, Review
• 11 Offenhauser N, Zinck T, Hoffmann J. et al . CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion.  Cephalalgia. 2005;  25 225-236
• 12 Reuter U, Bolay H, Jansen-Olesen I. et al . Delayed inflammation in rat meninges: implications for migraine pathophysiology.  Brain. 2001;  124 2490-2502
• 13 Schmidt Wilcke T, Leinisch E, Straube A. et al . Gray matter decrease in patients with chronic tension type headache.  Neurology. 2005;  65 1483-1486
• 14 Ashina M, Bendtsen L, Jensen R. et al . Plasma levels of calcitonin gene-related peptide in chronic tension-type headache.  Neurology. 2000;  55 1335-1340
• 15 Ashina M, Bendtsen L, Jensen R. et al . Possible mechanisms of glyceryl-trinitrate-induced immediate headache in patients with chronic tension-type headache.  Cephalalgia. 2000;  20 919-924
• 16 Waeber C, Moskowitz M A. Migraine as an inflammatory disorder.  Neurology. 2005;  64 9-15
• 17 Rajakariar R, Yaqoob M M, Gilroy D W. COX-2 in inflammation and resolution.  Mol Interv. 2006;  6 199-207
• 18 Packman E, Packman B, Thirsten H, Tseng L. Lumiracoxib is effective in the treatment of episodic tension-type headache.  Headache. 2005;  45 1163-1170
• 19 Schuh-Hofer S, Tayefeh M, Reuter U. et al . Effects of parecoxib on plasma protein extravasation and c-fos expression in the rat.  Headache. 2006;  46 276-285
• 20 Buzzi M G, Sakas D E, Moskowitz M A. Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater.  Eur J Pharmacol. 1989;  165 251-258
• 21 Sarchielle P, Alberti A, Codini M. et al . Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks.  Cephalalgia. 2000;  20 907-918
• 22 Nozaki K, Moskowitz M A, Boccalini P. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.  Br J Pharmacol. 1992;  106 409-415
• 23 Kaube H, Keay K A, Hoskin K L. et al . Expression of c-fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat.  Brain Res. 1993 a;  629 95-102
• 24 Goadsby P J, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.  Ann Neurol. 1990;  28 183-187
• 25 Tvedskoy J F, Lipka K, Ashina M. et al . No increase of calcitonin gene-related peptide in jugular blood during migraine.  Ann Neurol. 2005;  58 561-568
• 26 Hou L, Li W, Wang X. Mechanism of interleukin-1 beta-induced calcitonin gene-related peptide production from dorsal root ganglion neurons of neonatal rats.  J Neurosci Res. 2003;  73 188-197